{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:52:38Z","timestamp":1787021558691,"version":"build-2736575974"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1309\/r2q9ccuvtlrycf3h","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T16:33:14Z","timestamp":1176913994000},"page":"707-722","source":"Crossref","is-referenced-by-count":165,"title":["Anaplastic Large Cell Lymphoma"],"prefix":"10.1093","volume":"127","author":[{"given":"L. Jeffrey","family":"Medeiros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo S.J.","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"E00001","unstructured":"Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. <i>Blood.<\/i> 1985;66:848-858."},{"key":"E00002","unstructured":"Delsol G, Ralfkiaer E, Stein H, et al. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, et al, eds. <i>World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.<\/i> Lyon, France: IARC Press; 2001:230-235."},{"key":"E00003","unstructured":"Stein H, Foss HD, Durkop H, et al. CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. <i>Blood.<\/i> 2000;96:3681-3695."},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Falini B. Anaplastic large cell lymphoma: pathological, molecular and clinical features. <i>Br J Haematol.<\/i> 2001;114:741-760.","DOI":"10.1046\/j.1365-2141.2001.02896.x"},{"key":"E00005","unstructured":"Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. <i>Blood.<\/i> 1997;89:1394-1404."},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"The non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. <i>Blood.<\/i> 1997;89:3909-3915.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"E00007","unstructured":"Haralambieva E, Pulford KAF, Lamant L, et al. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas. <i>Br J Haematol.<\/i> 2000;109:584-591."},{"key":"E00008","unstructured":"Falini B, Pileri S, Zinzani PL, et al. ALK+ lymphoma: clinico-pathological findings and outcome. <i>Blood.<\/i> 1999;93:2697-2706."},{"key":"E00009","unstructured":"Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. <i>Blood.<\/i> 1999;83:3913-3921."},{"key":"E00010","unstructured":"Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. <i>Blood.<\/i> 1998;91:2076-2084."},{"key":"E00011","unstructured":"Shiota M, Nakamura S, Ichinohasama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM\/ALK: a distinct clinicopathologic entity. <i>Blood.<\/i> 1995;86:1954-1960."},{"key":"E00012","unstructured":"Nakamura S, Shiota M, Nakagawa A, et al. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80 (NPM\/ALK) expression. <i>Am J Surg Pathol.<\/i> 1997;29:838-839."},{"key":"E00013","unstructured":"Allory Y, Merabet Z, Copie-Bergman C, et al. Sarcomatoid variant of anaplastic large cell lymphoma mimics ALK-1-positive inflammatory myofibroblastic tumor in bladder. <i>Am J Surg Pathol.<\/i> 2005;28:1609-1614."},{"key":"E00014","unstructured":"Bonzheim I, Geissinger E, Roth S, et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. <i>Blood.<\/i> 2004;104:3358-3360."},{"key":"E00015","unstructured":"Foss HD, Anagnostopoulos L, Araujo L, et al. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. <i>Blood.<\/i> 1996;88:4005-4011."},{"key":"E00016","unstructured":"Rassidakis GZ, Sarris AH, Herling M, et al. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T\/null-cell lineage. <i>Am J Pathol.<\/i> 2001;159:527-535."},{"key":"E00017","unstructured":"Lae ME, Ahmed I, Macon WR. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. <i>Am J Clin Pathol.<\/i> 2002;118:773-779."},{"key":"E00018","unstructured":"Saffer H, Wahed A, Rassidakis GZ, et al. Clusterin expression in malignant lymphomas: a survey of 266 cases. <i>Mod Pathol.<\/i> 2002;15:1221-1226."},{"key":"E00019","unstructured":"Herling M, Rassidakis GZ, Jones D, et al. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria. <i>Hum Pathol.<\/i> 2004;35:455-459."},{"key":"E00020","unstructured":"Juco J, Holden JT, Mann KP, et al. Immunophenotypic analysis of anaplastic large cell lymphoma by flow cytometry. <i>Am J Clin Pathol.<\/i> 2003;1119:205-212."},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Onciu M, Behm FG, Raimondi SC, et al. ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis: report of three cases and review of the literature. <i>Am J Clin Pathol.<\/i> 2003;<b>120<\/b>:617-625.","DOI":"10.1309\/WH8PNU9PK4RRV852"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Al-Shamkhani A. The role of CD30 in the pathogenesis of haematopoietic malignancies. <i>Curr Opin Pharmacol.<\/i> 2004;4:355-359.","DOI":"10.1016\/j.coph.2004.02.007"},{"key":"E00023","unstructured":"Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. <i>Nature.<\/i> 1982;299:65-67."},{"key":"E00024","unstructured":"Pulford K, Morris SW, Turturro F. Anaplastic lymphoma kinase proteins in growth control and cancer. <i>J Cell Physiol.<\/i> 2004;199:330-358."},{"key":"E00025","unstructured":"Lamant L, Pulford K, Bischof D, et al. Expression of the <i>ALK<\/i> tyrosine kinase gene in neuroblastoma. <i>Am J Pathol.<\/i> 2000;156:1711-1721."},{"key":"E00026","unstructured":"Pillay K, Govender D, Chetty R. ALK protein expression in rhabdomyosarcomas. <i>Histopathology.<\/i> 2002;41:461-467."},{"key":"E00027","unstructured":"Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. <i>Mod Pathol.<\/i> 2001;14:569-576."},{"key":"E00028","unstructured":"Lawrence B, Perez-Atayde A, Hibbard MK, et al. <i>TPM3-ALK<\/i> and <i>TPM4-ALK<\/i> oncogenes in inflammatory myofibroblastic tumors. <i>Am J Pathol.<\/i> 2000;157:377-384."},{"key":"E00029","doi-asserted-by":"crossref","unstructured":"Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. <i>Blood.<\/i> 2003;<b>102<\/b>:2642-2644.","DOI":"10.1182\/blood-2003-04-1095"},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Gascoyne RD, Lamant L, Martin-Subero JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with clathrin-ALK rearrangements: report of 6 cases. <i>Blood.<\/i> 2003;<b>102<\/b>:2568-2573.","DOI":"10.1182\/blood-2003-03-0786"},{"key":"E00031","unstructured":"Delsol G, Lamant L, Mariame B, et al. A new subtype of large B-cell lymphoma expressing ALK kinase and lacking the 2;5 translocation. <i>Blood.<\/i> 1997;89:1483-1490."},{"key":"E00032","unstructured":"Vega F, Medeiros LJ. Chromosomal translocations involved in non-Hodgkin lymphomas. <i>Arch Pathol Lab Med.<\/i> 2003;127:1148-1160."},{"key":"E00033","unstructured":"Duyster J, Bai RY, Morris SW. Translocations involving anaplastic lymphoma kinase (ALK). <i>Oncogene.<\/i> 2001;20:5623-5637."},{"key":"E00034","unstructured":"Naoe T, Suzuki T, Kiyoi H, et al. NucleophosmIn: a versatile molecule associated with hematological malignancies. <i>Cancer Sci.<\/i> 2006;97:963-969."},{"key":"E00035","unstructured":"Sarris AH, Luthra R, Cabanillas F, et al. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms. <i>Leuk Lymphoma.<\/i> 1998;29:507-514."},{"key":"E00036","unstructured":"Falini B, Pulford K, Pucciarini A, et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. <i>Blood.<\/i> 1999;94:3509-3515."},{"key":"E00037","unstructured":"Lim MS, Elenitoba-Johnson KS. Mass spectrometry\u2014based proteomic studies of human anaplastic large cell lymphoma. <i>Mol Cell Proteomics.<\/i> 2006;5:1787-1798."},{"key":"E00038","unstructured":"Ten Berghe RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects: a review. <i>J Pathol.<\/i> 2003;200:4-15."},{"key":"E00039","unstructured":"Ten Berghe RL, de Bruin PC, Oudejans JJ, et al. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified. <i>Histopathology.<\/i> 2003;43:462-469."},{"key":"E00040","unstructured":"Ralfkiaer E, Delsol G, Willemze R, et al. Primary cutaneous CD30-positive T-cell lymphoproliferative disorders. In: Jaffe ES, Harris NL, Stein H, et al, eds. <i>World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.<\/i> Lyon, France: IARC Press; 2001:221-224."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/5\/707\/4988013\/ajcpath127-0707.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T08:44:29Z","timestamp":1587458669000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/R2Q9CCUVTLRYCF3H"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1309\/R2Q9CCUVTLRYCF3H"],"URL":"https:\/\/doi.org\/10.1309\/r2q9ccuvtlrycf3h","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}